1. Home
  2. ABCL vs BLND Comparison

ABCL vs BLND Comparison

Compare ABCL & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.65

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Blend Labs Inc.

BLND

Blend Labs Inc.

HOLD

Current Price

$3.18

Market Cap

894.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
BLND
Founded
2012
2012
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
894.7M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ABCL
BLND
Price
$3.65
$3.18
Analyst Decision
Buy
Buy
Analyst Count
5
6
Target Price
$7.75
$4.80
AVG Volume (30 Days)
3.7M
4.0M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,325,000.00
$167,532,000.00
Revenue This Year
$25.45
N/A
Revenue Next Year
$10.07
$19.81
P/E Ratio
N/A
N/A
Revenue Growth
7.17
37.61
52 Week Low
$1.89
$2.50
52 Week High
$6.52
$5.34

Technical Indicators

Market Signals
Indicator
ABCL
BLND
Relative Strength Index (RSI) 41.40 49.24
Support Level $3.51 $3.18
Resistance Level $3.84 $3.40
Average True Range (ATR) 0.18 0.14
MACD 0.08 0.03
Stochastic Oscillator 55.68 48.89

Price Performance

Historical Comparison
ABCL
BLND

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

Share on Social Networks: